Business Standard

Monday, December 23, 2024 | 07:21 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests

Firms claim breakthrough with their RNA-marker tech which detects cancer even in stage zero

Why aren't cancer drugs better? The targets might be wrong
Premium

The blood test gives results in 72 hours now and can tell if one has cancer or has a chance of getting it

Sohini Das Mumbai
Tzar Labs, a molecular diagnostic company, and Mumbai-based Epigeneres Biotechnology, have claimed a breakthrough with their RNA-marker based technology for early detection of cancer rooted in stem cell biology. The blood tests, which can help determine whether cancer is absent, imminent, or present and also detect the different stages of the disease; will be launched by the end of this year.

Ashish Tripathi, founder and CEO of Tzar Labs, said that they are awaiting the regulatory approvals, and are building the first laboratory in Mumbai now. “We want to have labs in Delhi, Mumbai, Bangalore and Hyderabad to begin with.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in